- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06360835
Our Experience in the Management of Therapeutic Failures of Fractures of the Proximal End of the Femur (About 35 Cases)
Osteosyntheses employed in treating fractures at the upper end of the femur play a critical role in facilitating a swift recovery by minimizing immobilization periods and enabling early rehabilitation of the affected joints, thereby promoting a speedy return to normal walking function.
Osteosynthesis alters the mechanical dynamics of the bone segment, which undergoes continual changes during the consolidation and mobilization phases of recovery. Throughout these stages, a range of mechanical complications may arise, posing challenges despite the successful prevention of infections. Non-infectious complications associated with the presence of osteosynthesis materials, especially in weight-bearing areas like the lower limb, remain a concern.
In light of these considerations, surgeons must exercise meticulous care in selecting synthetic materials to mitigate the risk of osteosynthesis failures. In cases where internal fixation fails, the standard recourse often involves converting to total hip arthroplasty (THA).
However, it is essential to note that THA subsequent to complications arising from proximal femur osteosynthesis presents a higher incidence of both intraoperative and postoperative complications compared to the implantation of primary total hip prostheses. Thus, while osteosynthesis remains a valuable intervention for femur fractures, careful attention to material selection and postoperative management is crucial in optimizing patient outcomes and minimizing complications.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Kairouan, Tunisia, 3190
- IBN jazzar hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
• Diagnosis of a fracture of the proximal end of the femur.
- Subsequent surgical intervention(s) due to failure of initial surgical treatment
Exclusion Criteria:
• Those initially treated with total hip arthroplasty.
- Patients lost to follow-up, not consistently monitored, or untreated after diagnosis of the complication.
- Cases with incomplete medical records
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
cases of recurrent fractures of the proximal end of the femur following surgical treatment failure
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgical Approach
Time Frame: from enrollment to the of treatment 6 years
|
type of approach
|
from enrollment to the of treatment 6 years
|
Preparation of the Patient
Time Frame: from enrollment to the of treatment 6 years
|
type of preparation
|
from enrollment to the of treatment 6 years
|
Anesthesia
Time Frame: from enrollment to the of treatment 6 years
|
type of anesthesia
|
from enrollment to the of treatment 6 years
|
Type of Surgical Revision
Time Frame: from enrollment to the of treatment 6 years
|
material implanted for revision
|
from enrollment to the of treatment 6 years
|
Types of Prosthesis
Time Frame: from enrollment to the of treatment 6 years
|
prothesis used
|
from enrollment to the of treatment 6 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age Distribution
Time Frame: from enrollment to the end of treatment 6 years
|
The average age of patients experiencing therapeutic failure after surgical treatment of proximal femur fractures was 66 years, with ages ranging from 28 to 94 years.
The age group 50-90 years constituted 68.59% of cases.
|
from enrollment to the end of treatment 6 years
|
Distribution by Sex
Time Frame: from enrollment to the end of treatment 6 years
|
Females represented a slight majority in the study, accounting for 57% (20 women), while males comprised 43% (15 men).
|
from enrollment to the end of treatment 6 years
|
Distribution According to Affected Side
Time Frame: from enrollment to the end of treatment 6 years
|
The right side was affected in 60% (21 cases), while the left side was affected in 40% (14 cases).
|
from enrollment to the end of treatment 6 years
|
Distribution According to Circumstances of Trauma
Time Frame: from enrollment to the end of treatment 6 years
|
Fractures were predominantly due to minimal trauma, with rare occurrences related to road accidents or domestic falls, attributed to bone fragility and muscle atrophy.
One case of a pathological fracture was observed in a patient with dislocation of an intermediate hip prosthesis due to ovarian cancer.
|
from enrollment to the end of treatment 6 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00001193
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Proximal Femur Fractures
-
AO Clinical Investigation and Publishing DocumentationCompletedProximal Femur FracturesUnited States, Switzerland, Austria
-
Mansoura UniversityCompleted
-
Hadassah Medical OrganizationUnknownProximal Femur FractureIsrael
-
Hospital Regional TlalnepantlaCompleted
-
Jenny BajracharyaUnknownFracture of Proximal End of FemurNepal
-
Synthes GmbHSynthes Australia Pty LtdWithdrawnProximal or Diaphyseal Humerus Fracture | Diaphyseal or Distal Femur Fracture | Diaphyseal, Distal or Proximal Tibia FractureAustralia
-
Mansoura UniversityUnknown
-
Mansoura UniversityCompleted
-
University Hospital OstravaRecruitingProximal Femur FractureCzechia
-
The University of Hong KongRecruitingProximal Humeral Fracture | Distal Humerus Fracture | Distal Femur Fracture | Distal Tibia FractureHong Kong
Clinical Trials on total hip arthroplasty
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Suzhou MicroPort OrthoRecon Co. LTDCompleted
-
Orthopedic Hospital Vienna SpeisingCompletedTotal Hip ArthroplastyAustria
-
Istituto Clinico HumanitasCompleted
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Degenerative Arthritis | Revision ArthroplastyCanada
-
Rothman Institute OrthopaedicsCompleted
-
Western University, CanadaRecruiting
-
Zimmer BiometTerminatedJoint Diseases | Osteoarthritis, Hip | Avascular Necrosis of Hip | Congenital Dysplasia of the Hip | Degenerative Joint Disease of Hip | Rheumatoid Arthritis of Hip | Post-Traumatic Osteoarthritis of HipCanada
-
Smith & Nephew, Inc.TerminatedJoint DiseasesCanada, Germany, Belgium
-
Norwegian University of Science and TechnologyOrtoMedic A/S, Oslo; Scandinavian Customized Prosthesis (SCP)CompletedOsteoarthritis, Hip